Skip to content
  • Tuesday, 27 October 2026
  • 9:34 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The oral exposure challenge in PROTACs: What drug developers need to solve early
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Oct 13, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough in chemical biology to a validated clinical reality. In…

Read More
Laboratory Safety & Compliance

Navigating the Regulatory Complexity of Formaldehyde Exposure Monitoring in Modern Laboratory Environments

Layla Zulfa Oct 11, 2026 0

The use of passive dosimeter badges for monitoring formaldehyde exposure in laboratory settings has long been a cornerstone of industrial…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Oct 5, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has officially transitioned from a visionary academic concept to a cornerstone of modern clinical pharmacology.…

Read More
Laboratory Safety & Compliance

Decoding the Regulatory Landscape of Formaldehyde Exposure Monitoring in Modern Laboratories

Layla Zulfa Oct 3, 2026 0

The ubiquity of passive dosimeter badges in clinical and research laboratories has long been considered a cornerstone of institutional compliance.…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 27, 2026 0

The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. Food and Drug Administration’s approval of vepdegestrant,…

Read More
Laboratory Safety & Compliance

Navigating the Nuances of Formaldehyde Exposure Monitoring: Understanding OSHA Compliance and Passive Dosimetry

Layla Zulfa Sep 26, 2026 0

The laboratory landscape is built upon a foundation of standardized protocols, yet the methodologies used to ensure the safety of…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 20, 2026 0

The landscape of modern pharmacology shifted fundamentally in May 2026, when the U.S. Food and Drug Administration (FDA) granted approval…

Read More
Laboratory Safety & Compliance

Demystifying Formaldehyde Exposure Monitoring: Understanding the Regulatory Reality of Passive Dosimetry

Layla Zulfa Sep 18, 2026 0

The widespread use of passive dosimeter badges for formaldehyde monitoring in laboratory settings has long been a standard operating procedure,…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 12, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…

Read More
Laboratory Safety & Compliance

Navigating Formaldehyde Exposure Monitoring: Dissecting the Validity of Passive Dosimeter Badges in Laboratory Settings

Layla Zulfa Sep 11, 2026 0

The debate surrounding the efficacy of passive dosimeter badges for monitoring formaldehyde exposure has reached a point of professional contention…

Read More

Posts pagination

1 2 3
Polish and French Researchers Pioneer Optical Tornadoes in Ground State Using Liquid Crystal MicrocavitiesBehavioral Clues in Midlife Predict Lifespan in Groundbreaking StudyAbdominal Contractions and the Hydraulic Cleaning of the Brain: A New Discovery in the Link Between Physical Activity and Cognitive HealthThe planets may have been water-rich worlds
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ